These five health care stocks, all belonging to small- or micro-cap categories, notched the highest jump in Stocktwits ...

Controversy surrounded Hims & Hers’ commercial, called ‘Sick of the System’, in the lead up to America’s biggest sporting ...

Hong Kong biotech start-up works with university partners to conduct global clinical trials studying prevalent eye diseases.

The Hims brand has primed people to view both their everyday health and the natural-aging processes as problems that can be ...

"They’re priced for profits, not patients.” That’s the critique from Hims & Hers Health’s buzzy — and controversial — Super ...

Novo Nordisk boasts 45 million customers using its drug, which has caused a revolution in weight-loss treatment. But competitors are nipping at its heels.

Compounded semaglutide is legal, but it's not regulated in the same way as medications like Ozempic and Wegovy.

Analysis of the open label data from FLAMINGO-01 has commenced and has been conducted in a manner that maintains the study blind. A preliminary review of FLAMINGO-01 HLA data in both the HLA-A*02 ...

Dr Craig Koniver, a family physician in Charleston, South Carolina, said he currently has 200 patients using the same method ...

The FDA announced the approval of a new treatment for pneumonia caused by certain difficult-to-treat bacteria, offering hope ...